UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 112

Sortiert nach

Antigen-loaded monocyte administration induces potent therapeutic antitumor T cell responses

The Journal of clinical investigation, 2020-02, Vol.130 (2), p.774-788

2020

Volltextzugriff (PDF)

Transcriptional and epigenetic regulators of human CD8 + T cell function identified through orthogonal CRISPR screens

Nature genetics, 2023-12, Vol.55 (12), p.2211-2223

2023

Volltextzugriff (PDF)

Preventing Lck Activation in CAR T Cells Confers Treg Resistance but Requires 4-1BB Signaling for Them to Persist and Treat Solid Tumors in Nonlymphodepleted Hosts

Clinical cancer research, 2019-01, Vol.25 (1), p.358-368

2019

Volltextzugriff (PDF)

Generation of Tumor Targeted Dendritic Cell Vaccines with Improved Immunogenic and Migratory Phenotype

Methods in molecular biology (Clifton, N.J.), 2022, Vol.2410, p.609

2022

Volltextzugriff (PDF)

The In Vitro Differentiation of Human CD141+CLEC9A+ Dendritic Cells from Mobilized Peripheral Blood CD34+ Hematopoietic Stem Cells

Current protocols, 2022-04, Vol.2 (4), p.e410-n/a

2022

Volltextzugriff (PDF)

Ethanol Ablation Therapy Drives Immune-Mediated Antitumor Effects in Murine Breast Cancer Models

Cancers, 2022-09, Vol.14 (19), p.4669

2022

Volltextzugriff (PDF)

Peptide vaccines for the treatment of glioblastoma

Journal of neuro-oncology, 2015-07, Vol.123 (3), p.433-440

2015

Volltextzugriff (PDF)

Immunotoxin-αCD40 therapy activates innate and adaptive immunity and generates a durable antitumor response in glioblastoma models

Science translational medicine, 2023-02, Vol.15 (682), p.eabn5649

2023

Volltextzugriff (PDF)

Rindopepimut: a promising immunotherapeutic for the treatment of glioblastoma multiforme

Immunotherapy, 2014-06, Vol.6 (6), p.679-690

2014

Volltextzugriff (PDF)

A simple and enzyme-free method for processing infiltrating lymphocytes from small mouse tumors for ELISpot analysis

Journal of immunological methods, 2018-08, Vol.459, p.90-93

2018

Volltextzugriff (PDF)

Promising vaccines for treating glioblastoma

Expert opinion on biological therapy, 2018-11, Vol.18 (11), p.1159-1170

2018

Volltextzugriff (PDF)

Preconditioning Vaccine Sites for mRNA-Transfected Dendritic Cell Therapy and Antitumor Efficacy

Methods in molecular biology (Clifton, N.J.), 2016-01, Vol.1403, p.819

2016

Volltextzugriff (PDF)

Enhancing dendritic cell-based vaccination for highly aggressive glioblastoma

Expert opinion on biological therapy, 2015-01, Vol.15 (1), p.79-94

2015

Volltextzugriff (PDF)

Architectural and biochemical expressions of mustard gas keratopathy: preclinical indicators and pathogenic mechanisms

PloS one, 2012-08, Vol.7 (8), p.e42837

2012

Volltextzugriff (PDF)

1220 Orthogonal CRISPR screens to identify transcriptional and epigenetic regulators of human CD8 T cell function

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1346-A1346

2023

Volltextzugriff (PDF)

A conjoined universal helper epitope can unveil antitumor effects of a neoantigen vaccine targeting an MHC class I-restricted neoepitope

npj vaccines, 2021-01, Vol.6 (1), p.12-12, Article 12

2021

Volltextzugriff (PDF)

CD27 stimulation unveils the efficacy of linked class I/II peptide vaccines in poorly immunogenic tumors by orchestrating a coordinated CD4/CD8 T cell response

Oncoimmunology, 2018-12, Vol.7 (12), p.e1502904-e1502904

2018

Volltextzugriff (PDF)

Synthetic long peptide vaccines possessing a universal helper epitope can unmask the therapeutic effects of MHC I-restricted neoepitopes

The Journal of immunology (1950), 2020-05, Vol.204 (1_Supplement), p.91-91.26

2020

Volltextzugriff (PDF)

Monocytes outperform ex vivo generated dendritic cells as cellular vaccines to trigger cytotoxic T lymphocyte responses against cancer in pre-clinical models

The Journal of immunology (1950), 2019-05, Vol.202 (1_Supplement), p.70-70.20

2019

Volltextzugriff (PDF)

TMOD-14. CONJOINED CLASS I AND II EPITOPES ENHANCE NEOANTIGEN-TARGETED ACTIVE IMMUNOTHERAPY

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi218-vi218

2021

Volltextzugriff (PDF)

Pathogenesis of acute and delayed corneal lesions after ocular exposure to sulfur mustard vapor

Cornea, 2012-03, Vol.31 (3), p.280

2012

Volltextzugriff (PDF)

Preventing Lck activation in CAR T cells confers Treg resistance but requires 4-1BB signaling for them to persist and treat solid tumors in non-lymphodepleted hosts

Clinical cancer research, 2018-11, Vol.25 (1), p.358-368

2018

Volltextzugriff (PDF)

The right tool for the right job: the value of alternative patient experience measures

The Journal of ambulatory care management, 2013-07, Vol.36 (3), p.241

2013

Volltextzugriff (PDF)

The Development of Cancer Vaccines Targeting Neoantigens for the Treatment of Malignant Astrocytomas

Swartz, Adam Michael

2018

Volltextzugriff (PDF)

1 – 25 von 112

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(98)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(62)
Life Sciences & Biomedicine
(53)
Humans
(31)
Male
(16)
Female
(14)
Neurosciences & Neurology
(11)
Adult
(9)
Clinical Neurology
(9)
Immunotherapy
(9)
Aged
(8)
Middle Aged
(8)
Physical Sciences
(8)
Animals
(7)
Glioblastoma
(7)
Immunology
(7)
Lymphocytes
(7)
Social Sciences
(7)
Medicine, Research & Experimental
(6)
Public, Environmental & Occupational Health
(6)
Research & Experimental Medicine
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Antigen-loaded monocyte administration induces potent therapeutic antitumor T cell responses

Transcriptional and epigenetic regulators of human CD8 + T cell function identified through orthogonal CRISPR screens

Preventing Lck Activation in CAR T Cells Confers Treg Resistance but Requires 4-1BB Signaling for Them to Persist and Treat Solid Tumors in Nonlymphodepleted Hosts

Generation of Tumor Targeted Dendritic Cell Vaccines with Improved Immunogenic and Migratory Phenotype

The In Vitro Differentiation of Human CD141+CLEC9A+ Dendritic Cells from Mobilized Peripheral Blood CD34+ Hematopoietic Stem Cells

Ethanol Ablation Therapy Drives Immune-Mediated Antitumor Effects in Murine Breast Cancer Models

Peptide vaccines for the treatment of glioblastoma

Immunotoxin-αCD40 therapy activates innate and adaptive immunity and generates a durable antitumor response in glioblastoma models

Rindopepimut: a promising immunotherapeutic for the treatment of glioblastoma multiforme

A simple and enzyme-free method for processing infiltrating lymphocytes from small mouse tumors for ELISpot analysis

Promising vaccines for treating glioblastoma

Preconditioning Vaccine Sites for mRNA-Transfected Dendritic Cell Therapy and Antitumor Efficacy

Enhancing dendritic cell-based vaccination for highly aggressive glioblastoma

Architectural and biochemical expressions of mustard gas keratopathy: preclinical indicators and pathogenic mechanisms

1220 Orthogonal CRISPR screens to identify transcriptional and epigenetic regulators of human CD8 T cell function

A conjoined universal helper epitope can unveil antitumor effects of a neoantigen vaccine targeting an MHC class I-restricted neoepitope

CD27 stimulation unveils the efficacy of linked class I/II peptide vaccines in poorly immunogenic tumors by orchestrating a coordinated CD4/CD8 T cell response

Synthetic long peptide vaccines possessing a universal helper epitope can unmask the therapeutic effects of MHC I-restricted neoepitopes

Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma

Monocytes outperform ex vivo generated dendritic cells as cellular vaccines to trigger cytotoxic T lymphocyte responses against cancer in pre-clinical models

TMOD-14. CONJOINED CLASS I AND II EPITOPES ENHANCE NEOANTIGEN-TARGETED ACTIVE IMMUNOTHERAPY

Pathogenesis of acute and delayed corneal lesions after ocular exposure to sulfur mustard vapor

Preventing Lck activation in CAR T cells confers Treg resistance but requires 4-1BB signaling for them to persist and treat solid tumors in non-lymphodepleted hosts

The right tool for the right job: the value of alternative patient experience measures

The Development of Cancer Vaccines Targeting Neoantigens for the Treatment of Malignant Astrocytomas

Suchergebnisse filtern